Analytical Performance Parameters of Antigen Rapid Test Cards in Diagnostic Workflows

Introduction

Antigen rapid test (Ag-RDT) cards have become a cornerstone of modern diagnostic workflows, particularly during infectious disease outbreaks such as influenza and SARS-CoV-2. These lateral-flow immunoassays detect pathogen-specific proteins in patient samples, usually nasal or nasopharyngeal swabs, and return results in 15–30 minutes.

The expansion of antigen testing was driven by the urgent need for scalable, low-cost, point-of-care diagnostics. However, rapid turnaround comes at a trade-off: antigen tests generally offer lower analytical sensitivity than nucleic acid amplification tests (NAATs) such as PCR. Understanding the analytical performance parameters of antigen test cards is essential for determining when and how to use them reliably in diagnostic workflows.

Analytical Performance Parameters

Analytical performance describes how well a test detects and distinguishes the target analyte. For antigen rapid tests, the key measurable parameters include sensitivity, specificity, limit of detection (LOD), reproducibility, and predictive values.

1. Sensitivity (True Positive Rate)

• Definition: The proportion of infected individuals correctly identified by the test.

• Impact Factors:

  • Viral load in the collected sample.

  • Timing of sampling relative to the infection course (higher loads in symptomatic phases yield higher sensitivity).

  • Sample quality and collection technique.

• Values:

  • Antigen test sensitivity typically ranges from 50–85% relative to PCR.

  • Sensitivity increases substantially in individuals with Ct values <25 in PCR, indicating high viral loads.

2. Specificity (True Negative Rate)

• Definition: The proportion of non-infected individuals correctly identified as negative.

• Strength:

  • Most antigen tests have specificity >97–99%.

  • High specificity stems from antibody-antigen recognition, but cross-reactivity with closely related pathogens is a potential source of false positives.

3. Limit of Detection (LOD)

• Definition: The smallest amount of target antigen detectable above background.

• Comparison:

  • PCR LOD: ~10–100 genome copies per reaction.

  • Antigen test LOD: ~10³–10⁵ viral particles per mL.

• Implication: Antigen tests are most reliable in cases of high viral shedding, especially during peak infectivity.

4. Reproducibility and Robustness

• Reproducibility refers to the consistency of results across operators, test lots, and environments.

• Because antigen tests are operator-dependent, reproducibility relies on proper swab technique, timing, and buffer use.

5. Predictive Values (PPV, NPV)

• Positive Predictive Value (PPV): Probability that a positive result is truly positive.

• Negative Predictive Value (NPV): Probability that a negative result is truly negative.

• These values depend heavily on disease prevalence in the population being tested:

  • High prevalence → PPV increases, NPV decreases.

  • Low prevalence → NPV increases, PPV decreases.

Technical Comparison: Antigen Rapid Test Cards vs PCR

Detection Principle

• Antigen Tests: Capture viral proteins (e.g., nucleocapsid or spike proteins) using immobilized antibodies on a lateral flow membrane. Detection is visual, usually via colloidal gold or fluorescent labels.

• PCR: Detects and amplifies viral nucleic acids (RNA/DNA), enabling detection of extremely low target concentrations.

Turnaround Time

• Antigen Test: 15–30 minutes, suitable for real-time triage.

• PCR: 2–6 hours for the assay itself, with total turnaround often extending to 24–48 hours due to transport and batching.

Analytical Sensitivity

• PCR: Gold standard with >95% sensitivity.

• Antigen: Lower, but adequate during high viral load phases for effective detection of contagious individuals.

Equipment and Cost

• Antigen tests require minimal equipment, making them scalable and deployable in resource-limited settings.

• PCR requires specialized equipment (thermocyclers, extraction kits), trained staff, and laboratory infrastructure.

Expanded Performance Parameters Beyond Sensitivity/Specificity

1. Cross-Reactivity Testing

• Evaluates false positives due to non-target pathogens (e.g., other coronaviruses, influenza viruses, bacterial flora).

• Antigen tests undergo cross-reactivity panels during validation to confirm analytical specificity.

2. Interference Studies

• Chemicals (e.g., nasal sprays, medications) or substances in the specimen can affect assay performance.

• Validations often include testing common interferents to confirm robustness.

3. Stability and Shelf Life

• Storage conditions (room temperature vs refrigerated) impact antibody performance and buffer stability.

• Long-term stability is critical for deployment in field testing.

Applications of Antigen Rapid Tests

1. Point-of-Care (POC) Diagnostics

• In clinical offices, pharmacies, or emergency departments, rapid tests guide immediate patient isolation or treatment.

2. Community and Mass Screening

• Schools, airports, and workplaces use antigen tests for regular, repeated testing.

• The lower sensitivity is offset by the ability to test large numbers frequently.

3. Outbreak Monitoring

• In congregate settings (nursing homes, military bases, prisons), Ag-RDTs allow rapid detection and isolation of infectious individuals.

4. Epidemiological Surveillance

• Antigen tests provide quick estimates of disease prevalence in populations, guiding public health interventions.

Situations Where Antigen Tests Are Less Reliable

1. Low Viral Load Samples

   • Early incubation or late infection stages.

   • Asymptomatic carriers with viral loads below LOD.

2. Critical Clinical Settings

   • Transplant units, oncology wards, or immunocompromised patients where false negatives could have severe consequences.

3. Confirmatory Testing Needs

   • Negative antigen results in symptomatic individuals should be followed by PCR.

   • Positive results in low-prevalence settings may also need PCR confirmation.

Best Practices for Reliable Antigen Test Use

• Training: Proper swabbing and timing are essential to minimize false negatives.

• Adherence to Manufacturer Protocols: Deviations in buffer volume, incubation, or reading time reduce accuracy.

• Parallel PCR Validation: Early implementation in new settings should include PCR confirmation to benchmark local performance.

• Consider Prevalence: Use predictive values to interpret results within epidemiological context.

• Quality Assurance: Include routine verification with known positive/negative samples to maintain performance over time.

Broader Diagnostic Workflow Integration

Antigen tests should be viewed as complementary tools rather than replacements for molecular assays. A tiered diagnostic workflow might look like this:

1. Screening: Antigen rapid test for immediate triage.

2. Confirmation: PCR for symptomatic individuals testing negative or asymptomatic individuals in sensitive settings.

3. Epidemiological Support: Antigen testing to monitor outbreaks, PCR to refine prevalence estimates.

Conclusion

Antigen rapid test cards are valuable diagnostic tools offering speed, accessibility, and high specificity, making them well-suited for point-of-care testing, outbreak control, and population-level screening. Their limitations in sensitivity and LOD compared to PCR mean they should be applied thoughtfully—especially in low-prevalence or high-risk contexts.

By understanding analytical performance parameters—sensitivity, specificity, LOD, reproducibility, and predictive values—clinicians and public health professionals can deploy antigen rapid tests as part of integrated diagnostic workflows, ensuring both rapid decision-making and accurate disease monitoring.